Page 1

Appendix 4E Preliminary final report 1 . Details of reporting period Name of entity ABN Reporting Year Previous Corresponding Year Race Oncology Limited 61 149 318 749 Year ended 30 June 2021 Year ended 30 June 2020 2. Results for announcement to the market Key information Revenues from ordinary activities Loss from ordinary activities after tax attributable to members Net loss for the year attributable to members 3 . Net tangible asset per share 18,847 12 months ended 30 June 2021 12 months ended 30 June 2020 Increase / ( decrease ) Amount change $ $ % $ 9,316 102 % 9,531 ( 6,340,319 ) ( 3,845,965 ) 65 % ( $ 2,494,354 ) ( 6,340,319 ) ( 3,845,965 ) 65 % ( $ 2,494,354 ) 0.070 0.015 Statement of profit or loss and other comprehensive income Refer to attached financial statements . 4 . Statement of financial position 5 . Refer to attached financial statements . Statement of cash flows Refer to attached financial statements . 6. Statement of changes in equity 7 . Refer to attached financial statements . Dividends / Distributions No dividends declared in current or prior year . 8. Details of dividend reinvestment plans N / A Page | 1